<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Retina Vitreous</journal-id><journal-id journal-id-type="iso-abbrev">Int J Retina Vitreous</journal-id><journal-title-group><journal-title>International Journal of Retina and Vitreous</journal-title></journal-title-group><issn pub-type="epub">2056-9920</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39891252</article-id><article-id pub-id-type="pmc">PMC11786427</article-id><article-id pub-id-type="publisher-id">638</article-id><article-id pub-id-type="doi">10.1186/s40942-025-00638-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Automated and code-free development of a risk calculator using ChatGPT-4 for predicting diabetic retinopathy and macular edema without retinal imaging</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Choi</surname><given-names>Eun Young</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Choi</surname><given-names>Joon Yul</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0890-8614</contrib-id><name><surname>Yoo</surname><given-names>Tae Keun</given-names></name><address><email>fawoo2@yonsei.ac.kr</email><email>eyetaekeunyoo@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01wjejq96</institution-id><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution>Department of Ophthalmology, Institute of Vision Research, </institution><institution>Gangnam Severance Hospital, Yonsei University College of Medicine, </institution></institution-wrap>Seoul, South Korea </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01wjejq96</institution-id><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution>Department of Biomedical Engineering, </institution><institution>Yonsei University, </institution></institution-wrap>Wonju, South Korea </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.517973.e</institution-id><institution>Department of Ophthalmology, </institution><institution>Hangil Eye Hospital, </institution></institution-wrap>35 Bupyeong-Daero, Bupyeong-Gu, Incheon, 21388 South Korea </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>11</volume><elocation-id>11</elocation-id><history><date date-type="received"><day>1</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Diabetic retinopathy (DR) and macular edema (DME) are critical causes of vision loss in patients with diabetes. In many communities, access to ophthalmologists and retinal imaging equipment is limited, making screening for diabetic retinal complications difficult in primary health care centers. We investigated whether ChatGPT-4, an advanced large-language-model chatbot, can develop risk calculators for DR and DME using health check-up tabular data without the need for retinal imaging or coding experience.</p></sec><sec><title>Methods</title><p id="Par2">Data-driven prediction models were developed using medical history and laboratory blood test data from diabetic patients in the Korea National Health and Nutrition Examination Surveys (KNHANES). The dataset was divided into training (KNHANES 2017&#x02013;2020) and validation (KNHANES 2021) datasets. ChatGPT-4 was used to build prediction formulas for DR and DME and developed a web-based risk calculator tool. Logistic regression analysis was performed by ChatGPT-4 to predict DR and DME, followed by the automatic generation of Hypertext Markup Language (HTML) code for the web-based tool. The performance of the models was evaluated using areas under the curves of receiver operating characteristic curve (ROC-AUCs).</p></sec><sec><title>Results</title><p id="Par3">ChatGPT-4 successfully developed a risk calculator for DR and DME, operational on a web browser without any coding experience. The validation set showed ROC-AUCs of 0.786 and 0.835 for predicting DR and DME, respectively. The performance of the ChatGPT-4 developed models was comparable to those created using various machine-learning tools.</p></sec><sec><title>Conclusion</title><p id="Par4">By utilizing ChatGPT-4 with code-free prompts, we overcame the technical barriers associated with using coding skills for developing prediction models, making it feasible to build a risk calculator for DR and DME prediction. Our approach offers an easily accessible tool for the risk prediction of DM and DME in diabetic patients during health check-ups, without the need for retinal imaging. Based on this automatically developed risk calculator using ChatGPT-4, health care workers will be able to effectively screen patients who require retinal examinations using only medical history and laboratory data. Future research should focus on validating this approach in diverse populations and exploring the integration of more comprehensive clinical data to enhance predictive performance.</p></sec><sec><title>Graphical Abstract</title><p id="Par5">
<graphic position="anchor" xlink:href="40942_2025_638_Figa_HTML" id="MO1"/></p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s40942-025-00638-9.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Diabetic retinopathy</kwd><kwd>Diabetic macular edema</kwd><kwd>ChatGPT-4</kwd><kwd>No-code</kwd><kwd>Code-free prompt</kwd><kwd>Risk calculator</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Brazilian Retina and Vitreous Society 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par25">Diabetes complications are a significant health problem worldwide for people with diabetes [<xref ref-type="bibr" rid="CR1">1</xref>]. Diabetic retinopathy (DR) and diabetic macular edema (DME) are the most common vision-threatening conditions among diabetic patients. If DR and DME are diagnosed early, the progression of the disease can be effectively prevented by controlling blood sugar levels, administering anti-VEGF or corticosteroid injections, and performing laser treatments. However, if the disease progresses, ischemia in the retinal tissue worsens, and new blood vessels grow, leading to a proliferative stage. Early diagnosis is very important, as progression to proliferative diabetic retinopathy and ischemic maculopathy stages can result in permanent vision loss [<xref ref-type="bibr" rid="CR2">2</xref>]. Therefore, it is recommended to undergo retinal examinations at least annually [<xref ref-type="bibr" rid="CR3">3</xref>]. Follow-up care after diabetes diagnosis usually includes blood tests to monitor blood sugar control and related systemic conditions. However, due to the lack of access to ophthalmologists in most countries, screening for DR and DME, which requires immediate retinal examination, is often not performed properly.</p><p id="Par26">To solve the problem of poor accessibility to eye clinics, studies have been conducted to identify risk groups for DR and DME that require retinal examinations based on medical history and laboratory blood test results [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Since the pathogenesis of diabetic complications is multifactorial [<xref ref-type="bibr" rid="CR6">6</xref>], a comprehensive analysis of healthcare data is necessary to predict DR and DME. For multivariate big data analysis, applying machine learning and deep learning models is more effective than using traditional statistical formulas. However, developing a model suitable for addressing the specific tasks of each clinical department requires complex coding skills, which poses a challenge for health care workers. Additionally, there are significant difficulties in directly applying the developed models to clinical settings [<xref ref-type="bibr" rid="CR7">7</xref>]. Most machine learning algorithms require downloading software with the trained model or accessing it through a server computer, which makes it difficult for clinicians to use [<xref ref-type="bibr" rid="CR8">8</xref>]. Differences in medical history profiles and laboratory tests between clinics, rising health care costs, and clinic overcrowding may also cause limited use of AI in clinical practice. The AI algorithms can only be used clinically if a user interface is provided in the form of a calculator that incorporates the formulas.</p><p id="Par27">Recent developments in large language models (LLMs) have enabled data analysis and software development without coding [<xref ref-type="bibr" rid="CR9">9</xref>]. ChatGPT-4, an advanced multimodal LLM by OpenAI, is capable of understanding and generating human-like text, making it a powerful tool for tasks such as natural language processing, data analysis, and even software development without the need for traditional coding skills. Although numerous functions of LLM are being introduced in ophthalmology [<xref ref-type="bibr" rid="CR10">10</xref>], research on their application in data analysis within the field remains limited. In this study, using ChatGPT-4, we automatically developed a risk calculator to screen for DR and DME risk groups in diabetic patients using data from the Korea National Health and Nutrition Examination Surveys (KNHANES). Through this study, we aimed to present a ChatGPT-4 based framework that can be easily applied in various medical fields to calculate the risk of major diseases without the need for a coding process (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Schematic diagram of this study</p></caption><graphic xlink:href="40942_2025_638_Fig1_HTML" id="MO2"/></fig></p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Dataset</title><p id="Par28">To construct a risk prediction model for DR and DME, we utilized data from diabetic patients collected through the Korea National Health and Nutrition Examination Survey (KNHANES). Conducted nationwide by the Korea Disease Control and Prevention Agency (KDCA), the KNHANES is a cross-sectional survey. The study protocol received approval from the KDCA Institutional Review Board, and informed consent was secured from all participants prior to their involvement. The dataset is publicly accessible for research purposes at <ext-link ext-link-type="uri" xlink:href="https://knhanes.kdca.go.kr/knhanes/eng/index.do">https://knhanes.kdca.go.kr/knhanes/eng/index.do</ext-link>. This research complied with the principles outlined in the Declaration of Helsinki. Participants were selected using stratified random sampling to ensure representation based on factors such as sex, age, and residential area [<xref ref-type="bibr" rid="CR11">11</xref>]. The dataset includes health records derived from interviews covering medical history, health behaviors, and nutrition surveys, alongside sociodemographic data, laboratory test results, and ophthalmologic examination outcomes [<xref ref-type="bibr" rid="CR12">12</xref>]. Laboratory assessments comprised standard blood tests and biochemical profiles, conducted after an overnight fast.</p><p id="Par29">The input data for model development included age, body mass index (BMI), waist circumference, household income level, smoking status, systolic blood pressure (SBP), diastolic blood pressure (DBP), duration of diabetes, use of oral or injectable antidiabetic drugs, and laboratory test results. The laboratory tests included white blood cell (WBC) count, hemoglobin, platelet counts, fasting glucose, total cholesterol, triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, and uric acid.</p><p id="Par30">The data workflow is illustrated in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. We selected the KNHANES data of the 2017&#x02013;2021 period because retinal disease grading was conducted based on retinal imaging within this 5-year period. Diabetes was defined by a fasting blood glucose&#x02009;&#x02265;&#x02009;126&#x000a0;mg/dL, glycated hemoglobin (HbA1c)&#x02009;&#x02265;&#x02009;6.5%, a diagnostic history of diabetes, or using any oral or injectable antidiabetic drugs. We established a study design to develop and validate prediction models in chronological order, with data split by calendar time. The DR and DME prediction models were developed using KNHANES data from 2017 to 2020 as the development dataset. Because the KNHANES randomly resamples participants yearly, the performance of the developed prediction models was evaluated using an independent dataset from KNHANES 2021. Accordingly, we used KNHANES 2021 data for external validation. Within the development sets, 80% of the data were randomly selected and used as the training dataset, while the remaining 20% were used as the internal validation dataset. Model training and validation were performed without normalizing the input variables.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Inclusion and exclusion of data in this study</p></caption><graphic xlink:href="40942_2025_638_Fig2_HTML" id="MO3"/></fig></p></sec><sec id="Sec4"><title>Definition of diabetic retinopathy and macular edema</title><p id="Par31">In the KNHANES, macular optical coherence tomography (OCT; Cirrus HD-OCT 500, Carl Zeiss Meditec, Jena, Germany) and non-mydriatic fundus photography (VISUCAM, Carl Zeiss Meditec) were utilized. DR and DME were evaluated by retinal specialists certified by the Korean Retina Society. Each fundus photograph and OCT image was independently assessed twice by an independent grader. In cases where there was disagreement in the initial diagnosis, a reading committee from the Korean Retina Society reviewed the images to establish a final consensus. The procedures and criteria used to define DR and DME in the KNHANES have been elaborated in prior research [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Clinically significant macular edema (CSME) was defined according to the following criteria, which include retinal thickening (&#x02265;&#x02009;300 microns) within 500 microns of the macular center, hard exudates within 500 microns of the macular center if associated with adjacent retinal thickening, or retinal thickening measuring one disc area or larger, with any part located within one disc diameter of the macular center [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Additionally, eyes that lacked typical CSME features but showed foveal thickening exceeding 300 microns, as documented by OCT within the ETDRS grid, were also classified as having cystoid macular edema. The Epidemiologic Survey Committee of the Korean Ophthalmologic Society (KOS) ensured the quality of eye examinations. To maintain consistency, members of the National Epidemiologic Survey Committee of the KOS regularly provided training to participating ophthalmologists and residents. The Korea Disease Control and Prevention Agency (KDCA) validated both the data collection protocols and overall data quality.</p></sec><sec id="Sec5"><title>Risk calculator development using ChatGPT-4</title><p id="Par32">Table <xref rid="Tab1" ref-type="table">1</xref> provides a comprehensive overview of the prompts used for performing logistic regression and constructing the DR and DME risk calculator. To begin, the training dataset was uploaded to ChatGPT-4 by dragging the file into the chat window. Logistic regression analysis was then conducted to predict DR, with input variables specified by listing the column names from the CSV file and clearly identifying the diabetic retinopathy variable as the target [<xref ref-type="bibr" rid="CR16">16</xref>]. Feature selection was carried out concurrently using a backward elimination approach during the regression process.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Prompts used to develop a risk calculator to predict diabetic retinopathy and macular edema</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Tasks</th><th align="left">Prompts</th></tr></thead><tbody><tr><td align="left">1. Load the training dataset</td><td align="left">(After dragging the training dataset into the dialog window) This data file is designed to predict diabetic retinopathy and diabetic macular edema using patients&#x02019; medical history and laboratory data</td></tr><tr><td align="left" rowspan="3">2. Develop DR prediction formula</td><td align="left"><p>Develop a formula to predict the occurrence of diabetic retinopathy using the following items</p><p>The variable targeted for prediction is E_DR (whether diabetic retinopathy occurs)</p><p>Please use logistic regression analysis using backward elimination feature selection method</p><p>Enter the following variables as input:</p><p>Sex, age, ho_incm, Dyslipidemia, DM_insulin, DM_duration, DM_po_med, Smoking, HE_sbp, HE_dbp, HE_wc, HE_BMI, HE_glu, HE_HbA1c, HE_chol, HE_TG, HE_ast, HE_alt, HE_HB, HE_BUN, HE_crea, HE_WBC, HE_Bplt, HE_Uacid</p></td></tr><tr><td align="left">Please show the final prediction formula to predict E_DR</td></tr><tr><td align="left">Draw the ROC curve of the E_DR prediction formula using the formula developed above. Show the optimal cutoff value</td></tr><tr><td align="left" rowspan="3">3. Develop DME prediction formula</td><td align="left"><p>Develop a formula to predict the occurrence of diabetic macular edema using the following items</p><p>The variable targeted for prediction is E_DME (whether diabetic macular edema occurs)</p><p>Please use logistic regression analysis using backward elimination feature selection method</p><p>Enter the following variables as input:</p><p>Sex, age, ho_incm, Dyslipidemia, DM_insulin, DM_duration, DM_po_med, Smoking, HE_sbp, HE_dbp, HE_wc, HE_BMI, HE_glu, HE_HbA1c, HE_chol, HE_TG, HE_ast, HE_alt, HE_HB, HE_BUN, HE_crea, HE_WBC, HE_Bplt, HE_Uacid</p></td></tr><tr><td align="left">Please show the final prediction formula to predict E_DR</td></tr><tr><td align="left">Draw the ROC curve of the E_DME prediction formula using the formula developed above. Show the optimal cutoff value</td></tr><tr><td align="left" rowspan="2">4. Organize formulas and input data</td><td align="left">Please describe the formulas to predict E_DR (diabetic retinopathy) and E_DME (diabetic macular edema), which were developed above. Show the cutoff values, mentioned above, of each formula to identify the high-risk groups</td></tr><tr><td align="left">What are the variables needed to calculate these formulas above?</td></tr><tr><td align="left" rowspan="2">5. Create HTML codes to build a risk calculator</td><td align="left"><p>Create a calculator that calculates the percentage risk scores of E_DR and E_DME using above formulas</p><p>Build the codes for the risk calculator written in html, css, and javascript in one html file</p><p>Design:</p><p>The text boxes must have rounded edges</p><p>Make this calculator look professional by creating a frame around it</p><p>Separate the title, input window and output window frames</p><p>Insert the title of the calculator in the title frame above the input window frame. The title is "Diabetic retinopathy (DR) and diabetic macular edema (DME) risk calculator"</p><p>Add the subtitle of the input window inside the frame: &#x0201c;Medical history and laboratory data&#x0201d;</p><p>Add the subtitle of the output window inside the frame: &#x0201c;DR and DME risk results&#x0201d;</p><p>The input frame should be above, and the output frame should be below. The title, input, and output frames must be aligned in order from the top</p><p>Input items:</p><p>Above-mentioned variables to calculate the formulas</p><p>Please show the units of the variables</p><p>Output items:</p><p>DR risk score (%)</p><p>Whether the calculation result corresponds to the DR high-risk or low-risk group</p><p>DME risk score (%)</p><p>Whether the calculation result corresponds to the DME high-risk or low-risk group</p></td></tr><tr><td align="left">Set the size of the calculator to 800 by 800 pixels. Input items are in three columns. Please keep the inputs and calculation information as are</td></tr><tr><td align="left">6. Validation of the developed DR and DME formulas</td><td align="left">(After dragging the test dataset into the dialog window) This is the dataset for the external validation. Please draw ROC curves of the developed formulas above to predict DR and DME. Calculate the sensitivity and specificity at the optimal cutoff using the Youden's index</td></tr></tbody></table><table-wrap-foot><p><italic>DME</italic> diabetic macular edema, <italic>DR</italic> diabetic retinopathy, <italic>ho_incm</italic> household income, <italic>HE_sbp</italic> systolic blood pressure, <italic>HE_dbp</italic> diastolic blood pressure, <italic>HE_wc</italic> waist circumference, <italic>HE_BMI</italic> body mass index, <italic>HE_glu</italic> fasting glucose level, <italic>HE_chol</italic> total cholesterol, <italic>HE_TG</italic> Triglyceride, <italic>HE_ast</italic> aspartate aminotransferase, <italic>HE_alt</italic> alanine aminotransferase, <italic>HE_HB</italic> hemoglobin, <italic>HE_BUN</italic> blood urea nitrogen, <italic>HE_crea</italic> creatinine, <italic>HE_WBC</italic> white blood cell count, <italic>HE_Bplt</italic> platelet count, <italic>HE_Uacid</italic> uric acid</p></table-wrap-foot></table-wrap></p><p id="Par33">Subsequently, we prompted ChatGPT-4 to explain the derived formulas within the chat interface, and the prediction performance was assessed through a receiver operating characteristic (ROC) curve. Validation datasets were similarly uploaded by dragging files into the chat window. Since ChatGPT-4 automatically identified the column names, no additional manipulation of variables or files was necessary.</p><p id="Par34">After establishing the prediction formulas for DR and DME, cutoff values for each prediction were verified, and the input variables were organized to facilitate the development of a calculator. Using these specifications, ChatGPT-4 was instructed to create DR and DME risk calculators in Hypertext Markup Language (HTML). The HTML code enabled the calculators to function as webpages, executable through any standard web browser. To improve the user interface, additional prompts were used to define specific design features of the calculator. The final code was saved as a single HTML file and successfully run in a web browser.</p></sec><sec id="Sec6"><title>Comparison analysis</title><p id="Par35">The performance of DR and DME prediction models developed in this study was compared with that of other machine learning algorithms using the same training set. The evaluation was conducted on both internal and external validation datasets. We adopted machine learning algorithms, including random forest (RF) with R version 4.2.1 (The Comprehensive R Archive Network; <ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org">http://cran.r-project.org</ext-link>) [<xref ref-type="bibr" rid="CR17">17</xref>], gradient boosting machine (GBM) using Orange Data Mining version 3.36.2 (Bioinformatics Laboratory, University of Ljubljana, Ljubljana, Slovenia) [<xref ref-type="bibr" rid="CR18">18</xref>], and support vector machine (SVM) with a radial basis function kernel using MATLAB 2022a (The MathWorks Inc., Natick, MA, USA) [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. These algorithms were selected based on their empirically demonstrated excellent performance in disease prediction. A grid search was conducted to evaluate the range of tunable parameter values with internal validation to obtain the best hyperparameters for each algorithm. In addition, HbA1c levels and disease duration, which are known to be important factors in the severity of diabetes, were compared with the predicted results as independent indicators [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par36">The results of the prediction models were evaluated using the area under the ROC curve (AUCs). Data were compared using the chi-square test for categorical variables and Student&#x02019;s t-test for continuous variables. The maximum Youden&#x02019;s index was used to determine the cutoff value. All tests were two-sided, with a significance level of P value&#x02009;&#x0003c;&#x02009;0.05. All ROC curve analyses were performed using MedCalc Version 22.021 (Mariakerke, Belgium).</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Demographics</title><p id="Par37">This study included 2,231 patients with diabetes in the development dataset and 229 patients in the external validation dataset. Of the development dataset, 1,785 patients were used for training, and 446 were used for the internal validation. The characteristics and laboratory data of patients with diabetes in this study are summarized in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Patients with DR had a longer duration of diabetes and a higher frequency of diabetes treatment (both oral medication and insulin treatment); higher SBP, HbA1c levels, and fasting glucose levels; and lower total cholesterol, AST, and hemoglobin levels compared to those without DR. Patients with DME were older; had a longer duration of diabetes and a higher frequency of diabetes treatment; higher SBP, HbA1c levels, and fasting glucose levels; and lower DBP, total cholesterol, AST, ALT, and hemoglobin levels compared to those without DME.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Demographic and laboratory data of the diabetic patients included in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variable</th><th align="left" colspan="3">DR</th><th align="left" colspan="3">DME</th></tr><tr><th align="left">DR group (N&#x02009;=&#x02009;503)</th><th align="left">No DR group (N&#x02009;=&#x02009;1957)</th><th align="left">P-value</th><th align="left">DME group (N&#x02009;=&#x02009;37)</th><th align="left">No DME group (N&#x02009;=&#x02009;2423)</th><th align="left">P-value</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td char="(" align="char">62.65 (10.32)</td><td char="(" align="char">62.80 (11.18)</td><td char="." align="char">0.772</td><td char="(" align="char">67.32 (10.63)</td><td char="(" align="char">62.70 (11.00)</td><td char="." align="char">0.012</td></tr><tr><td align="left">Sex (female)</td><td char="(" align="char">236 (46.9%)</td><td char="(" align="char">970 (49.5%)</td><td char="." align="char">0.312</td><td char="(" align="char">17 (45.9%)</td><td char="(" align="char">1189 (49.0%)</td><td char="." align="char">0.832</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td char="(" align="char">25.03 (3.50)</td><td char="(" align="char">25.61 (3.58)</td><td char="." align="char">0.001</td><td char="(" align="char">24.80 (3.46)</td><td char="(" align="char">25.50 (3.58)</td><td char="." align="char">0.153</td></tr><tr><td align="left">Waist circumference (cm)</td><td char="(" align="char">89.76 (9.41)</td><td char="(" align="char">88.88 (9.11)</td><td char="." align="char">0.089</td><td char="(" align="char">89.52 (9.35)</td><td char="(" align="char">88.95 (9.29)</td><td char="." align="char">0.566</td></tr><tr><td align="left">Current smoker</td><td char="(" align="char">111 (22.0%)</td><td char="(" align="char">363 (18.5%)</td><td char="." align="char">0.085</td><td char="(" align="char">6 (16.22%)</td><td char="(" align="char">468 (19.3%)</td><td char="." align="char">0.791</td></tr><tr><td align="left">House income (lowest quartile)</td><td char="(" align="char">150 (29.9%)</td><td char="(" align="char">578 (29.6%)</td><td char="." align="char">0.913</td><td char="(" align="char">15 (40.5%)</td><td char="(" align="char">713 (29.5%)</td><td char="." align="char">0.150</td></tr><tr><td align="left" colspan="7">DM history</td></tr><tr><td align="left">&#x000a0;DM duration (years)</td><td char="(" align="char">10.94 (10.02)</td><td char="(" align="char">5.87 (7.72)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td char="(" align="char">17.00 (11.01)</td><td char="(" align="char">6.75 (8.36)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x000a0;DM oral medication</td><td char="(" align="char">397 (78.9%)</td><td char="(" align="char">1174 (59.9%)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td char="(" align="char">35 (94.5%)</td><td char="(" align="char">1536 (63.3%)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x000a0;DM insulin treatment</td><td char="(" align="char">63 (12.52%)</td><td char="(" align="char">43 (2.20%)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td char="(" align="char">8 (21.62%)</td><td char="(" align="char">98 (4.04%)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" colspan="7">Blood pressure</td></tr><tr><td align="left">&#x000a0;SBP (mmHg)</td><td char="(" align="char">127.46 (16.50)</td><td char="(" align="char">125.46 (15.81)</td><td char="." align="char">0.014</td><td char="(" align="char">131.61 (16.68)</td><td char="(" align="char">125.78 (15.95)</td><td char="." align="char">0.041</td></tr><tr><td align="left">&#x000a0;DBP (mmHg)</td><td char="(" align="char">74.71 (10.53)</td><td char="(" align="char">75.24 (10.18)</td><td char="." align="char">0.307</td><td char="(" align="char">71.78 (9.97)</td><td char="(" align="char">75.19 (10.25)</td><td char="." align="char">0.046</td></tr><tr><td align="left" colspan="7">Laboratory tests</td></tr><tr><td align="left">&#x000a0;HbA1c (%)</td><td char="(" align="char">7.73 (1.57)</td><td char="(" align="char">7.02 (1.13)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td char="(" align="char">8.15 (1.63)</td><td char="(" align="char">7.15 (1.25)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x000a0;Fasting Glucose (mg/dL)</td><td char="(" align="char">151.36 (49.43)</td><td char="(" align="char">133.47 (33.32)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td char="(" align="char">156.41 (57.56)</td><td char="(" align="char">136.84 (37.43)</td><td char="." align="char">0.046</td></tr><tr><td align="left">&#x000a0;Total cholesterol (mg/dL)</td><td char="(" align="char">170.81 (42.66)</td><td char="(" align="char">176.26 (42.30)</td><td char="." align="char">0.010</td><td char="(" align="char">163.32 (33.21)</td><td char="(" align="char">175.33 (42.53)</td><td char="." align="char">0.036</td></tr><tr><td align="left">&#x000a0;Triglyceride (mg/dL)</td><td char="(" align="char">162.02 (133.10)</td><td char="(" align="char">160.74 (120.96)</td><td char="." align="char">0.845</td><td char="(" align="char">152.81 (83.80)</td><td char="(" align="char">161.13 (124.03)</td><td char="." align="char">0.556</td></tr><tr><td align="left">&#x000a0;AST (IU/L)</td><td char="(" align="char">25.94 (18.48)</td><td char="(" align="char">27.86 (14.50)</td><td char="." align="char">0.030</td><td char="(" align="char">21.78 (6.09)</td><td char="(" align="char">27.56 (15.50)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x000a0;ALT (IU/L)</td><td char="(" align="char">26.47 (27.17)</td><td char="(" align="char">28.91 (21.44)</td><td char="." align="char">0.062</td><td char="(" align="char">19.65 (10.20)</td><td char="(" align="char">28.55 (22.85)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x000a0;BUN (mg/dL)</td><td char="(" align="char">17.21 (5.95)</td><td char="(" align="char">16.74 (5.34)</td><td char="." align="char">0.106</td><td char="(" align="char">20.70 (7.70)</td><td char="(" align="char">16.78 (5.41)</td><td char="." align="char">0.003</td></tr><tr><td align="left">&#x000a0;Creatinine (mg/dL)</td><td char="(" align="char">0.88 (0.45)</td><td char="(" align="char">0.84 (0.24)</td><td char="." align="char">0.061</td><td char="(" align="char">1.09 (0.73)</td><td char="(" align="char">0.84 (0.28)</td><td char="." align="char">0.047</td></tr><tr><td align="left">&#x000a0;Uric acid (mg/dL)</td><td char="(" align="char">4.95 (1.45)</td><td char="(" align="char">5.07 (1.38)</td><td char="." align="char">0.110</td><td char="(" align="char">5.26 (1.40)</td><td char="(" align="char">5.04 (1.39)</td><td char="." align="char">0.345</td></tr><tr><td align="left">&#x000a0;WBC (10<sup>3</sup> cells/&#x003bc;L)</td><td char="(" align="char">6.72 (1.83)</td><td char="(" align="char">6.61 (1.78)</td><td char="." align="char">0.209</td><td char="(" align="char">7.16 (1.81)</td><td char="(" align="char">6.62 (1.79)</td><td char="." align="char">0.079</td></tr><tr><td align="left">&#x000a0;Platelet (10<sup>9</sup>/L)</td><td char="(" align="char">245.63 (61.94)</td><td char="(" align="char">248.68 (66.55)</td><td char="." align="char">0.332</td><td char="(" align="char">237.70 (63.18)</td><td char="(" align="char">248.21 (65.67)</td><td char="." align="char">0.322</td></tr><tr><td align="left">&#x000a0;Hemoglobin (mg/dL)</td><td char="(" align="char">13.86 (1.66)</td><td char="(" align="char">14.05 (1.60)</td><td char="." align="char">0.023</td><td char="(" align="char">13.28 (1.61)</td><td char="(" align="char">14.02 (1.61)</td><td char="." align="char">0.007</td></tr></tbody></table><table-wrap-foot><p><italic>AST</italic> aspartate aminotransferase, <italic>ALT</italic> alanine aminotransferase, <italic>BMI</italic> body mass index, <italic>BUN</italic> blood urea nitrogen, <italic>DBP</italic> diastolic blood pressure, <italic>DM</italic> diabetes mellitus, <italic>DME</italic> diabetic macular edema, <italic>DR</italic> diabetic retinopathy, <italic>SBP</italic> systolic blood pressure, <italic>WBC</italic> white blood cell count</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Development of a risk calculator</title><p id="Par38">During the development process to build prediction models using ChatGPT-4, the researchers used formal English and did not perform coding or mathematical calculations themselves. ChatGPT-4 successfully recognized the training data in a CSV file and understood the meaning of the column names. Following the prompts provided, ChatGPT-4 performed logistic regression with feature selection to build formulas for DR and DME predictions (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The results of the logistic regression analysis with feature selection performed using ChatGPT-4, along with the calculated odds ratios, are presented in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. To predict DR, the final model included the variables: age, BMI, duration of diabetes, oral medication, insulin treatment, SBP, HbA1c, fasting glucose, and hemoglobin levels. For predicting DME, the formulas included the variables: diabetes duration, SBP, HbA1c, creatinine, WBC count, platelet count, and hemoglobin level. The exact process was followed for predicting DME within the same dialog window without entering a new dataset.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Screenshot of examples of regression analysis performed by ChatGPT-4. <bold>A</bold> Loading a dataset and development of a formula. <bold>B</bold> Development of new formulas based on context without additional data loading. <bold>C</bold> Data loading and evaluation for external validation</p></caption><graphic xlink:href="40942_2025_638_Fig3_HTML" id="MO4"/></fig><table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Logistic regression with feature selection performed by ChatGPT-4 for diabetic retinopathy using the training dataset</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="3">Diabetic retinopathy</th><th align="left" colspan="3">Diabetic macular edema</th></tr><tr><th align="left">Coefficient</th><th align="left">OR (95% CI)</th><th align="left">P-value</th><th align="left">Coefficient</th><th align="left">OR (95% CI)</th><th align="left">P-value</th></tr></thead><tbody><tr><td align="left">Age (years, per 1 unit increase)</td><td align="left">&#x02212;0.020</td><td align="left">0.98 (0.97&#x02013;0.99)</td><td align="left">0.002</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>, per 1 unit increase)</td><td align="left">&#x02212;0.043</td><td align="left">0.96 (0.93&#x02013;0.99)</td><td align="left">0.011</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">DM duration (years, per 1 unit increase)</td><td align="left">0.038</td><td align="left">1.04 (1.02&#x02013;1.06)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">0.058</td><td align="left">1.06 (1.04&#x02013;1.10)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">DM oral medication</td><td align="left">0.682</td><td align="left">1.97 (1.37&#x02013;2.44)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">DM insulin treatment</td><td align="left">1.068</td><td align="left">2.91 (1.93&#x02013;4.75)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">SBP (mmHg, per 1 unit increase)</td><td align="left">0.015</td><td align="left">1.02 (1.00&#x02013;1.03)</td><td align="left">0.001</td><td align="left">0.024</td><td align="left">1.03 (1.01&#x02013;1.05)</td><td align="left">0.014</td></tr><tr><td align="left">HbA1c (%, per 1 unit increase)</td><td align="left">0.205</td><td align="left">1.23 (1.11&#x02013;1.39)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">0.534</td><td align="left">1.70 (1.27&#x02013;2.00)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Fasting glucose (mg/dL, per 1 unit increase)</td><td align="left">0.007</td><td align="left">1.01 (1.00&#x02013;1.01)</td><td align="left">0.002</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">Creatinine (mg/dL, per 1 unit increase)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">0.765</td><td align="left">2.15 (1.38&#x02013;3.03)</td><td align="left">0.021</td></tr><tr><td align="left">WBC (cells/&#x003bc;L, per 1 unit increase)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">0.200</td><td align="left">1.22 (1.02&#x02013;1.51)</td><td align="left">0.033</td></tr><tr><td align="left">Platelet (10<sup>9</sup>/L, per 1 unit increase)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02212;0.006</td><td align="left">0.99 (0.98&#x02013;0.99)</td><td align="left">0.025</td></tr><tr><td align="left">Hemoglobin (mg/dL, per 1 unit increase)</td><td align="left">&#x02212;0.074</td><td align="left">0.93 (0.86&#x02013;0.99)</td><td align="left">0.034</td><td align="left">&#x02212;0.366</td><td align="left">0.79 (0.57&#x02013;0.92)</td><td align="left">0.007</td></tr><tr><td align="left">Constant</td><td align="left">&#x02212;3.167</td><td align="left">&#x02013;</td><td align="left">0.002</td><td align="left">&#x02212;7.731</td><td align="left">&#x02013;</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Multivariate logistic regression analysis using all variables</p><p><sup>&#x02020;</sup>Multivariable logistic regression with stepwise backward selection model</p></table-wrap-foot></table-wrap></p><p id="Par39">After establishing all the formulas to predict DR and DME, we immediately instructed ChatGPT-4 to build a calculator using HTML (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). ChatGPT-4 automatically generated HTML code that can be executed on a web browser to create a risk calculator. As shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, the code was generated based on the context of previous conversations, and the input, output, and mathematical formulas were not entered separately into the prompt. The codes generated by ChatGPT-4 are shown in the Supplementary Materials. Using Calculator, users can run the saved HTML code file on a web browser. The calculator worked well without errors in both the desktop and mobile environments. This calculator is available at <ext-link ext-link-type="uri" xlink:href="https://taekeuntoo.github.io/DR_DME_risk_calc/">https://taekeuntoo.github.io/DR_DME_risk_calc/</ext-link>.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Risk calculator development process. The HTML code generated by ChatGPT-4 was opened in a web browser to run the developed calculator. This calculator is available at <ext-link ext-link-type="uri" xlink:href="https://taekeuntoo.github.io/DR_DME_risk_calc/">https://taekeuntoo.github.io/DR_DME_risk_calc/</ext-link>. <italic>HE_sbp</italic> systolic blood pressure, <italic>HE_BMI</italic> body mass index, <italic>HE_glu</italic> fasting glucose level, <italic>HE_HB</italic> hemoglobin, <italic>HE_crea</italic> creatinine, <italic>HE_WBC</italic> white blood cell count, <italic>HE_Bplt</italic> platelet count</p></caption><graphic xlink:href="40942_2025_638_Fig4_HTML" id="MO5"/></fig></p></sec><sec id="Sec11"><title>Comparison of prediction models</title><p id="Par40">We evaluated the performance of the formulas established by ChatGPT-4 by comparing them with machine learning algorithms developed using various tools. Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> shows the ROC curves for internal and external validations. In the internal validation set, the developed formula exhibited ROC AUCs of 0.747 and 0.940 for predicting DR and DME, respectively. In the external validation set, the formula showed an ROC-AUCs of 0.786 and 0.835 for predicting DR and DME, respectively. The fine-tuned RF from R exhibited the best performance in predicting DR (AUC&#x02009;=&#x02009;0.800) and DME (AUC&#x02009;=&#x02009;0.851) in the external validation.<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>ROC curves for diabetic retinopathy (DR) and diabetic macular edema (DME) prediction. <bold>A</bold> DR prediction in the internal validation set. <bold>B</bold> DME prediction in the internal validation set. <bold>C</bold> DR prediction in the external validation set. <bold>D</bold> DR prediction in the external validation set</p></caption><graphic xlink:href="40942_2025_638_Fig5_HTML" id="MO6"/></fig></p><p id="Par41">Table <xref rid="Tab4" ref-type="table">4</xref> shows the detailed performance metrics used to predict DR. In the prediction of DR, the logistic regression formula from ChatGPT-4 showed no significant difference compared to RF and GBM in internal and external validations. Logistic regression outperformed SVM in the internal validation and diabetes indicators (HbA1c and diabetes duration) in internal and external validations. Table <xref rid="Tab5" ref-type="table">5</xref> lists the performance metrics used to predict the DME. In terms of DME, the logistic regression formula from ChatGPT-4 showed no significant difference compared to the other machine learning algorithms in both internal and external validations. It showed high predictive performance compared to diabetes indicators but did not show significance due to the small sample size. Diabetes duration and HbA1c levels were identified as important factors in feature selection for both RF (Supplementary Material 2) and GBM (Supplementary Material 3), and there was no significant difference from the feature selection results constructed by ChatGPT-4.<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Prediction performance of developed algorithms and diabetes indicators for diabetic retinopathy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">ROC-AUC [95% CI]</th><th align="left">Accuracy (%), [95% CI]</th><th align="left">Sensitivity (%), [95% CI]</th><th align="left">Specificity (%), [95% CI]</th><th align="left">P-value*</th></tr></thead><tbody><tr><td align="left" colspan="6">Internal validation</td></tr><tr><td align="left">&#x000a0;LR (ChatGPT-4)</td><td align="left">0.747 [0.703, 0.786]</td><td align="left">72.0 [67.6, 76.1)</td><td align="left">64.2 [53.7, 73.8)</td><td align="left">74.1 [69.2, 78.7]</td><td align="left">Reference</td></tr><tr><td align="left">&#x000a0;RF&#x000a0;(R)</td><td align="left">0.746 [0.703, 0.786]</td><td align="left">73.3 [68.9, 77.4]</td><td align="left">58.9 [48.3, 68.9]</td><td align="left">77.3 [72.5, 81.6]</td><td align="left">0.995</td></tr><tr><td align="left">&#x000a0;GBM (Orange)</td><td align="left">0.737 [0.694, 0.778]</td><td align="left">68.4 [63.8, 72.7]</td><td align="left">71.6 [61.4, 80.3]</td><td align="left">67.5 [62.3, 72.4]</td><td align="left">0.169</td></tr><tr><td align="left">&#x000a0;SVM (MATLAB)</td><td align="left">0.695 [0.650, 0.738]</td><td align="left">64.1 [59.4, 68.5]</td><td align="left">68.4 [58.1, 77.6]</td><td align="left">62.9 [57.6, 68.0]</td><td align="left">0.008</td></tr><tr><td align="left">&#x000a0;HbA1c</td><td align="left">0.660 [0.616, 0.706]</td><td align="left">69.5 [65.0, 73.8]</td><td align="left">55.8 [45.2, 65.9]</td><td align="left">73.2 [68.2, 77.8]</td><td align="left">0.002</td></tr><tr><td align="left">&#x000a0;DM duration</td><td align="left">0.682 [0.637, 0.725]</td><td align="left">63.4 [58.7, 67.9]</td><td align="left">65.2 [54.8, 74.7]</td><td align="left">62.9 [57.6, 68.0]</td><td align="left">0.004</td></tr><tr><td align="left" colspan="6">External validation</td></tr><tr><td align="left">&#x000a0;LR (ChatGPT-4)</td><td align="left">0.786 [0.726, 0.837]</td><td align="left">74.4 [68.3, 79.9]</td><td align="left">77.2 [62.1, 88.5]]</td><td align="left">73.7 [66.7, 79.9]</td><td align="left">Reference</td></tr><tr><td align="left">&#x000a0;RF&#x000a0;(R)</td><td align="left">0.800 [0.742, 0.851]</td><td align="left">74.0 [67.8, 79.6]</td><td align="left">81.8 [67.3, 91.8]</td><td align="left">72.1 [65.0, 78.5]</td><td align="left">0.194</td></tr><tr><td align="left">&#x000a0;GBM (Orange)</td><td align="left">0.771 [0.710, 0.824]</td><td align="left">70.9 [64.6, 76.7]</td><td align="left">79.5 [64.7, 90.2]</td><td align="left">68.8 [61.6, 75.5]</td><td align="left">0.168</td></tr><tr><td align="left">&#x000a0;SVM (MATLAB)</td><td align="left">0.714 [0.650, 0.772]</td><td align="left">69.6 [63.1, 75.5]</td><td align="left">70.4 [54.8, 83.2]</td><td align="left">69.4 [62.1, 75.9]</td><td align="left">0.051</td></tr><tr><td align="left">&#x000a0;HbA1c</td><td align="left">0.699 [0.635, 0.758]</td><td align="left">57.7 [51.0, 64.2]</td><td align="left">79.5 [64.7, 90.2]</td><td align="left">52.5 [44.9, 59.9]</td><td align="left">0.034</td></tr><tr><td align="left">&#x000a0;DM duration</td><td align="left">0.697 [0.632, 0.756]</td><td align="left">62.9 [56.3, 69.3]</td><td align="left">77.2 [62.1, 88.5]</td><td align="left">59.5 [52.1, 66.7]</td><td align="left">0.029</td></tr></tbody></table><table-wrap-foot><p><italic>CI</italic> confidence interval, <italic>DM</italic> diabetes mellitus, <italic>GBM</italic> gradient boosting machine, <italic>LR</italic> logistic regression, <italic>ROC-AUC</italic> area under the receiver operating characteristic curve, <italic>SVM</italic> support vector machine</p><p><sup>*</sup>Differences in ROC-AUC values compared to the logistic regression performed using ChatGPT-4</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>Prediction performance of developed algorithms and diabetes indicators for diabetic macular edema</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">ROC-AUC [95% CI]</th><th align="left">Accuracy (%), [95% CI]</th><th align="left">Sensitivity (%), [95% CI]</th><th align="left">Specificity (%), [95% CI]</th><th align="left">P-value*</th></tr></thead><tbody><tr><td align="left" colspan="6">Internal validation</td></tr><tr><td align="left">&#x000a0;LR (ChatGPT-4)</td><td align="left">0.940 [0.914, 0.960]</td><td align="left">85.6 [82.0, 88.7]</td><td align="left">100.0 [59.0, 100.0]</td><td align="left">85.4 [81.7, 88.5]</td><td align="left">Reference</td></tr><tr><td align="left">&#x000a0;RF&#x000a0;(R)</td><td align="left">0.918 [0.888, 0.942]</td><td align="left">84.0 [80.3, 87.3]</td><td align="left">100.0 [59.0, 100.0]</td><td align="left">83.8 [79.9, 87.1]</td><td align="left">0.261</td></tr><tr><td align="left">&#x000a0;GBM (Orange)</td><td align="left">0.955 [0.931, 0.972]</td><td align="left">86.5 [82.9, 89.5]</td><td align="left">100.0 [59.0, 100.0]</td><td align="left">86.3 [82.7, 89.3]</td><td align="left">0.463</td></tr><tr><td align="left">&#x000a0;SVM (MATLAB)</td><td align="left">0.892 [0.859, 0.919]</td><td align="left">78.2 [74.1, 81.9]</td><td align="left">85.7 [42.1, 99.6]</td><td align="left">78.1 [73.9, 81.8]</td><td align="left">0.368</td></tr><tr><td align="left">&#x000a0;HbA1c</td><td align="left">0.896 [0.865, 0.924]</td><td align="left">68.5 [64.0, 72.8]</td><td align="left">100.0 [59.0, 100.0]</td><td align="left">68.0 [63.4, 72.4]</td><td align="left">0.328</td></tr><tr><td align="left">&#x000a0;DM duration</td><td align="left">0.765 [0.724, 0.804]</td><td align="left">49.9 [45.1, 54.6]</td><td align="left">100.0 [59.0, 100.0]</td><td align="left">49.1 [44.3, 53.8]</td><td align="left">0.007</td></tr><tr><td align="left" colspan="6">External validation</td></tr><tr><td align="left">&#x000a0;LR (ChatGPT-4)</td><td align="left">0.835 [0.780, 0.881]</td><td align="left">66.3 [59.8, 72.4]</td><td align="left">100.0 [29.2, 100.0]</td><td align="left">65.9 [59.3, 72.1]</td><td align="left">Reference</td></tr><tr><td align="left">&#x000a0;RF&#x000a0;(R)</td><td align="left">0.851 [0.798, 0.895]</td><td align="left">69.4 [63.0, 75.3]</td><td align="left">100.0 [29.2, 100.0]</td><td align="left">69.0 [62.5, 74.9]</td><td align="left">0.414</td></tr><tr><td align="left">&#x000a0;GBM (Orange)</td><td align="left">0.851 [0.798, 0.895]</td><td align="left">71.6 [65.3, 77.3]</td><td align="left">100.0 [29.2, 100.0]</td><td align="left">71.2 [64.8, 77.0]</td><td align="left">0.805</td></tr><tr><td align="left">&#x000a0;SVM (MATLAB)</td><td align="left">0.757 [0.695, 0.811]</td><td align="left">82.5 [76.9, 87.2]</td><td align="left">66.7 [9.4, 99.1]</td><td align="left">82.7 [77.2, 87.4]</td><td align="left">0.308</td></tr><tr><td align="left">&#x000a0;HbA1c</td><td align="left">0.821 [0.765, 0.869]</td><td align="left">72.5 [66.2, 78.2]</td><td align="left">100.0 [29.2, 100.0]</td><td align="left">72.1 [65.8, 77.8]</td><td align="left">0.819</td></tr><tr><td align="left">&#x000a0;DM duration</td><td align="left">0.770 [0.710, 0.824]</td><td align="left">60.3 [53.6, 66.6]</td><td align="left">100.0 [29.2, 100.0]</td><td align="left">59.7 [53.0, 66.2]</td><td align="left">0.609</td></tr></tbody></table><table-wrap-foot><p><italic>CI</italic> confidence interval, <italic>DM</italic> diabetes mellitus, <italic>GBM</italic> gradient boosting machine, <italic>LR</italic> logistic regression, <italic>ROC-AUC</italic> area under the receiver operating characteristic curve, <italic>SVM</italic> support vector machine</p><p><sup>*</sup>Differences in ROC-AUC values compared to the logistic regression performed using ChatGPT-4</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par42">This study is the first to design an automated risk calculator, operational on a web browser, for predicting DR and DME risks using a LLM without the need for retinal imaging or a coding process. Access to ophthalmologists and retinal imaging equipment is still limited in most communities, making retinal examination difficult to perform in all health screening centers [<xref ref-type="bibr" rid="CR22">22</xref>]. Our proposed method can efficiently address these difficulties in DR and DME screening. Our approach using ChatGPT-4 is highly cost-effective and can accelerate the clinical application of algorithms developed to screen DR and DME through a rapid development cycle and reflection of feedback.</p><p id="Par43">Most clinicians have only encountered chronic disease risk analysis models in research papers, making it challenging to apply these analyses in clinical practice [<xref ref-type="bibr" rid="CR23">23</xref>]. Clinicians need to enhance the efficiency and effectiveness of their clinical processes based on AI [<xref ref-type="bibr" rid="CR7">7</xref>]. By following the methodology of this study, clinicians can use ChatGPT-4 to overcome barriers to coding skills, directly analyze risk factors, and develop prediction models. This allows for the creation of a risk calculator that can be conveniently used directly in clinical practice, enabling more patients to assess their disease risk and benefit more directly. In addition, ChatGPT-4 simplifies the process of updating calculators based on new data, allowing clinicians to create customized chronic disease risk calculators using data from their own institutions. The coding capabilities of LLM have already been confirmed and are actively used in many industry [<xref ref-type="bibr" rid="CR24">24</xref>]. We expect that the development of automated calculators in the medical field will benefit many clinicians and patients with limited access to medical care.</p><p id="Par44">Instead of focusing on retinal imaging, we proposed a new method that utilizes clinical and laboratory data to reveal patterns associated with complication of metabolic disease. By applying the numerical data-based calculator development approach for DR and DME proposed in this study, patients requiring retinal examinations can be effectively screened. Previous studies have identified demographic and biological risk factors for DR and DME through statistical analyses using national study data [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Recently, machine learning approaches have been proposed to predict the occurrence of DR based on larger-scale data [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Most studies have used complex tree-based algorithms like RF or XGBoost to improve performance [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. The calculator in this study is based on HTML and can operate as a web browser application, even offline, without a server connection. This means it can be used on any computer at a medical institution. Generally, developing and running a machine learning model requires initial development costs for GPU usage and ongoing server maintenance costs. However, an HTML-based calculator using ChatGPT-4 incurs no such development costs and is easy to maintain. Our experimental results showed that the prediction results of the regression analysis and machine learning were statistically similar. Therefore, clinicians will be able to calculate the risk of DR and DME in diabetic patients with accuracy and reliability using the calculator proposed in this study.</p><p id="Par45">Several studies have consistently reported the difficulty of developing machine learning algorithms that show optimal performance across various external validation sets [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In a disease prediction model, it is challenging to achieve both fitting and generalization of the data simultaneously [<xref ref-type="bibr" rid="CR31">31</xref>]. Instead of large-scale validation of algorithms developed after collecting big data, another alternative could be for individual institutions to produce customized algorithms and apply them to clinical trials [<xref ref-type="bibr" rid="CR18">18</xref>]. Using the method proposed in this study, individual organizations can easily create customized risk calculators with the data they collect. Each institution has a unique patient population and testing equipment. The prevalence and risk factors for diabetic complications may vary depending on socioeconomic environment, genetic background, and lifestyle. In this study, we used sample data from South Korea; however, it is possible to develop a customized risk calculator for DR and DME with higher performance by utilizing data collected from individual hospitals using ChatGPT-4. Previously, data analysis experts were required to develop individual algorithms [<xref ref-type="bibr" rid="CR32">32</xref>]. However, our study showed that not only many data analysis processes but also the design of algorithms and creation of user interfaces could be replaced by ChatGPT-4. Researchers from other institutions and countries can use their data to develop customized risk calculators that can be easily used in clinical practice.</p><p id="Par46">DR and DME are closely related and predictable based on systemic multi-factors such as hyperglycemia, hypertension, duration of diabetes, and genetic factor [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Increased neutrophil counts, reflecting a systemic inflammatory state, are also known to be associated with the development of DR [<xref ref-type="bibr" rid="CR34">34</xref>]. The developed DR and DME risk calculators linearly combined known clinical risk factors and laboratory test results. Since there was no statistical difference in diagnostic performance between the nonlinear machine learning and linear logistic regression models, it appears that there is no specific nonlinear relationship between the variables in predicting DR and DME. In addition, the importance analysis from AI tools and the feature selection from ChatGPT-4&#x02019;s regression analysis showed similar results.</p><p id="Par47">Most studies using AI chatbots in the medical field have been limited to confirming diagnoses or plans using their knowledge [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. This study went beyond the scope of previous studies by demonstrating that direct statistical processing and software production were possible without coding. During our research with ChatGPT-4, we observed several advantages and disadvantages. The benefits of this method include ChatGPT-4&#x02019;s ability to recognize data names and provide various insights. For example, it recognized the &#x0201c;glucose level&#x0201d; and &#x0201c;HbA1c&#x0201d; names, provided the normal range, and appropriately handled the imputation of missing data. In addition, the data summary and analysis processes were explained in the chat window. The feature selection and regression analysis processes were detailed, allowing the researcher to review for errors. A disadvantage of ChatGPT-4 was that the answers to the same questions are not always consistent. The algorithm of ChatGPT-4 uses internal randomness to generate various answers and select the optimal one [<xref ref-type="bibr" rid="CR37">37</xref>]. In addition, hallucinations can occur if the prompt is nonspecific. When coding, unspecified items were often processed arbitrarily according to the context. While delegating the details of analysis and software to ChatGPT-4 was convenient, it sometimes produced hallucinations. Therefore, when developing a risk calculator using ChatGPT-4, it is essential to clearly specify the requirements for analysis methods and coding.</p><p id="Par48">This study had several limitations. First, the cross-sectional nature of data collection in the KNHANES hinders the development of a prediction model for the future development of DR and DME [<xref ref-type="bibr" rid="CR38">38</xref>]. Longitudinal follow-up data are required to build developmental prediction models; however, large-scale cross-sectional studies such as ours provide meaningful insights. Second, the data were collected from an East Asian country, raising uncertainty about the generalizability of our models to other countries or ethnic groups. It is recommended that ChatGPT-4 be used to establish individual calculation formulas with data specific to each ethnic group as both DR and DME risks may differ [<xref ref-type="bibr" rid="CR39">39</xref>]. Third, our dataset includes variables such as blood glucose levels and BMI measurements, which fluctuated during data collection. These variations can introduce noise into the predictions and reduce accuracy.</p><p id="Par49">Another notable limitation is that the dataset included only diabetic patients, which restricts the applicability of the risk calculator to broader populations containing both diabetic and non-diabetic individuals. In mixed populations, the overall accuracy of predicting diabetic retinopathy is expected to increase, but sensitivity and specificity may be significantly affected by the presence of other ophthalmic conditions with overlapping features, such as hypertensive retinopathy. To address these challenges, future studies should test the calculator on datasets representing more diverse populations. This would help evaluate its performance, account for the impact of coexisting conditions, and refine the algorithm for wider clinical use.</p></sec><sec id="Sec13"><title>Conclusion</title><p id="Par50">The risk calculator developed using ChatGPT-4 demonstrated moderate accuracy in predicting DR and DME, with performance metrics comparable to traditional machine learning algorithms. Additionally, this calculator runs in a web browser using ChatGPT-4, allowing clinicians to quickly identify patients who require detailed retinal examinations at the point of care. Our approach offers an easily accessible tool that enables risk prediction of DM and DME in routine health check-up screening for patients with diabetes. However, it is important to acknowledge that the dataset used comprised only diabetic patients, which may limit the generalizability of the model to broader populations. Additionally, the reliance on self-reported medical history and laboratory data, which can be subject to variability, may affect the precision of predictions. Future research should focus on validating this approach in diverse populations and exploring the integration of more comprehensive clinical data to enhance predictive performance.</p></sec><sec id="Sec14" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40942_2025_638_MOESM1_ESM.pdf"><caption><p>Supplementary material 1: Material 1. HTML codes generated by ChatGPT-4. Material 2. SHAP feature importances from random forest models developed using R. Material 3. Feature importance from gradient boosting machine models developed using Orange Data Mining.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ALT</term><def><p id="Par6">Alanine aminotransferase</p></def></def-item><def-item><term>AST</term><def><p id="Par7">Aspartate aminotransferase</p></def></def-item><def-item><term>BMI</term><def><p id="Par8">Body mass index</p></def></def-item><def-item><term>BUN</term><def><p id="Par9">Blood urea nitrogen</p></def></def-item><def-item><term>CSME</term><def><p id="Par10">Clinically significant macular edema</p></def></def-item><def-item><term>DBP</term><def><p id="Par11">Diastolic blood pressure</p></def></def-item><def-item><term>DME</term><def><p id="Par12">Diabetic macular edema</p></def></def-item><def-item><term>DR</term><def><p id="Par13">Diabetic retinopathy</p></def></def-item><def-item><term>GBM</term><def><p id="Par14">Gradient boosting machine</p></def></def-item><def-item><term>HbA1c</term><def><p id="Par15">Glycated hemoglobin</p></def></def-item><def-item><term>HTML</term><def><p id="Par16">Hypertext Markup Language</p></def></def-item><def-item><term>KNHANES</term><def><p id="Par17">Korea National Health and Nutrition Examination Survey</p></def></def-item><def-item><term>LLM</term><def><p id="Par18">Large language model</p></def></def-item><def-item><term>OCT</term><def><p id="Par19">Optical coherence tomography</p></def></def-item><def-item><term>RF</term><def><p id="Par20">Random forest</p></def></def-item><def-item><term>ROC-AUC</term><def><p id="Par21">Receiver operating characteristic area under the curve</p></def></def-item><def-item><term>SBP</term><def><p id="Par22">Systolic blood pressure</p></def></def-item><def-item><term>SVM</term><def><p id="Par23">Support vector machine</p></def></def-item><def-item><term>WBC</term><def><p id="Par24">White blood cell count</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Eun Young Choi and Joon Yul Choi have contributed equally as co-first authors.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Eun Young Choi: Writing&#x02014;review &#x00026; editing, Writing&#x02014;original draft, Visualization, Validation, Software, Methodology, Investigation, Formal analysis. Joon Yul Choi: Writing&#x02014;review &#x00026; editing, Writing&#x02014;original draft, Visualization, Software, Investigation, Formal analysis. Tae Keun Yoo: Conceptualization, Project administration, Resources, Supervision, Writing&#x02014;review &#x00026; editing.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>None.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The dataset is publicly available for research at <ext-link ext-link-type="uri" xlink:href="https://knhanes.kdca.go.kr/knhanes/eng/index.do">https://knhanes.kdca.go.kr/knhanes/eng/index.do</ext-link>.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par51">The KNHANES is a cross-sectional survey conducted nationwide by the Korea Disease Control and Prevention Agency (KDCA). Approval for the study protocol was granted by the Institutional Review Board of the KDCA, and informed consent was obtained from participants prior to their involvement. The dataset is publicly accessible for research purposes at <ext-link ext-link-type="uri" xlink:href="https://knhanes.kdca.go.kr/knhanes/eng/index.do">https://knhanes.kdca.go.kr/knhanes/eng/index.do</ext-link>.&#x000a0;This study complies with the principles outlined in the Declaration of Helsinki.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par52">Not applicable, as this study does not include identifiable individual data, images, or personal information requiring consent for publication.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par53">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Mauricio</surname><given-names>D</given-names></name><name><surname>Alonso</surname><given-names>N</given-names></name><name><surname>Gratac&#x000f2;s</surname><given-names>M</given-names></name></person-group><article-title>Chronic diabetes complications: the need to move beyond classical concepts</article-title><source>Trends Endocrinol Metab</source><year>2020</year><volume>31</volume><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2020.01.007</pub-id><pub-id pub-id-type="pmid">32033865</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Mauricio D, Alonso N, Gratac&#x000f2;s M. Chronic diabetes complications: the need to move beyond classical concepts. Trends Endocrinol Metab. 2020;31:287&#x02013;95.<pub-id pub-id-type="pmid">32033865</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>CY</given-names></name><name><surname>Maguire</surname><given-names>MG</given-names></name><name><surname>Flaxel</surname><given-names>CJ</given-names></name><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effectiveness of conventional digital fundus photography-based teleretinal screening for diabetic retinopathy and diabetic macular Edema: a report by the American academy of ophthalmology</article-title><source>Ophthalmology</source><year>2024</year><pub-id pub-id-type="doi">10.1016/j.ophtha.2024.02.017</pub-id><pub-id pub-id-type="pmid">39733838</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Weng CY, Maguire MG, Flaxel CJ, Jain N, Kim SJ, Patel S, et al. Effectiveness of conventional digital fundus photography-based teleretinal screening for diabetic retinopathy and diabetic macular Edema: a report by the American academy of ophthalmology. Ophthalmology. 2024. 10.1016/j.ophtha.2024.02.017.<pub-id pub-id-type="pmid">39733838</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PP</given-names></name><name><surname>Feldman</surname><given-names>ZW</given-names></name><name><surname>Ostermann</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>DS</given-names></name><name><surname>Sloan</surname><given-names>FA</given-names></name></person-group><article-title>Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases</article-title><source>Ophthalmology</source><year>2003</year><volume>110</volume><fpage>1952</fpage><lpage>1959</lpage><pub-id pub-id-type="doi">10.1016/S0161-6420(03)00817-0</pub-id><pub-id pub-id-type="pmid">14522771</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003;110:1952&#x02013;9.<pub-id pub-id-type="pmid">14522771</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>E</given-names></name><name><surname>Yoo</surname><given-names>TK</given-names></name><name><surname>Park</surname><given-names>E-C</given-names></name></person-group><article-title>Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study</article-title><source>BMC Med Inform Decis Mak</source><year>2013</year><volume>13</volume><fpage>106</fpage><pub-id pub-id-type="doi">10.1186/1472-6947-13-106</pub-id><pub-id pub-id-type="pmid">24033926</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Oh E, Yoo TK, Park E-C. Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study. BMC Med Inform Decis Mak. 2013;13:106.<pub-id pub-id-type="pmid">24033926</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Using machine learning techniques to develop risk prediction models for the risk of incident diabetic retinopathy among patients with type 2 diabetes mellitus: a cohort study</article-title><source>Front Endocrinol</source><year>2022</year><pub-id pub-id-type="doi">10.3389/fendo.2022.876559</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Zhao Y, Li X, Li S, Dong M, Yu H, Zhang M, et al. Using machine learning techniques to develop risk prediction models for the risk of incident diabetic retinopathy among patients with type 2 diabetes mellitus: a cohort study. Front Endocrinol. 2022. 10.3389/fendo.2022.876559.</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Antonetti</surname><given-names>DA</given-names></name><name><surname>Silva</surname><given-names>PS</given-names></name><name><surname>Stitt</surname><given-names>AW</given-names></name></person-group><article-title>Current understanding of the molecular and cellular pathology of diabetic retinopathy</article-title><source>Nat Rev Endocrinol</source><year>2021</year><volume>17</volume><fpage>195</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/s41574-020-00451-4</pub-id><pub-id pub-id-type="pmid">33469209</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17:195&#x02013;206.<pub-id pub-id-type="pmid">33469209</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Pumplun</surname><given-names>L</given-names></name><name><surname>Fecho</surname><given-names>M</given-names></name><name><surname>Wahl</surname><given-names>N</given-names></name><name><surname>Peters</surname><given-names>F</given-names></name><name><surname>Buxmann</surname><given-names>P</given-names></name></person-group><article-title>Adoption of machine learning systems for medical diagnostics in clinics: qualitative interview study</article-title><source>J Med Internet Res</source><year>2021</year><volume>23</volume><fpage>e29301</fpage><pub-id pub-id-type="doi">10.2196/29301</pub-id><pub-id pub-id-type="pmid">34652275</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Pumplun L, Fecho M, Wahl N, Peters F, Buxmann P. Adoption of machine learning systems for medical diagnostics in clinics: qualitative interview study. J Med Internet Res. 2021;23:e29301.<pub-id pub-id-type="pmid">34652275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Vellido</surname><given-names>A</given-names></name></person-group><article-title>The importance of interpretability and visualization in machine learning for applications in medicine and health care</article-title><source>Neural Comput &#x00026; Applic</source><year>2020</year><volume>32</volume><fpage>18069</fpage><lpage>18083</lpage><pub-id pub-id-type="doi">10.1007/s00521-019-04051-w</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Vellido A. The importance of interpretability and visualization in machine learning for applications in medicine and health care. Neural Comput &#x00026; Applic. 2020;32:18069&#x02013;83.</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="book"><person-group person-group-type="author"><name><surname>Busch</surname><given-names>D</given-names></name><name><surname>Bainczyk</surname><given-names>A</given-names></name><name><surname>Steffen</surname><given-names>B</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kofro&#x00148;</surname><given-names>J</given-names></name><name><surname>Margaria</surname><given-names>T</given-names></name><name><surname>Seceleanu</surname><given-names>C</given-names></name></person-group><article-title>Towards LLM-based system migration in language-driven engineering</article-title><source>Engineering of computer-based systems</source><year>2024</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer Nature Switzerland</publisher-name><fpage>191</fpage><lpage>200</lpage></element-citation><mixed-citation id="mc-CR9" publication-type="book">Busch D, Bainczyk A, Steffen B. Towards LLM-based system migration in language-driven engineering. In: Kofro&#x00148; J, Margaria T, Seceleanu C, editors. Engineering of computer-based systems. Cham: Springer Nature Switzerland; 2024. p. 191&#x02013;200.</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Bellanda</surname><given-names>VCF</given-names></name><name><surname>dos Santos</surname><given-names>ML</given-names></name><name><surname>Ferraz</surname><given-names>DA</given-names></name><name><surname>Jorge</surname><given-names>R</given-names></name><name><surname>Melo</surname><given-names>GB</given-names></name></person-group><article-title>Applications of ChatGPT in the diagnosis, management, education, and research of retinal diseases: a scoping review</article-title><source>Int J Retin Vitr</source><year>2024</year><volume>10</volume><fpage>79</fpage><pub-id pub-id-type="doi">10.1186/s40942-024-00595-9</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Bellanda VCF, dos Santos ML, Ferraz DA, Jorge R, Melo GB. Applications of ChatGPT in the diagnosis, management, education, and research of retinal diseases: a scoping review. Int J Retin Vitr. 2024;10:79.</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name></person-group><article-title>Prevalence and risk factors of epiretinal membrane: data from the Korea national health and nutrition examination survey VII (2017&#x02013;2018)</article-title><source>Clin Experiment Ophthalmol</source><year>2022</year><volume>50</volume><fpage>1047</fpage><lpage>1056</lpage><pub-id pub-id-type="doi">10.1111/ceo.14164</pub-id><pub-id pub-id-type="pmid">36073108</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Kim JS, Kim M, Kim SW. Prevalence and risk factors of epiretinal membrane: data from the Korea national health and nutrition examination survey VII (2017&#x02013;2018). Clin Experiment Ophthalmol. 2022;50:1047&#x02013;56.<pub-id pub-id-type="pmid">36073108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Kweon</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Jang</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Choi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)</article-title><source>Int J Epidemiol</source><year>2014</year><volume>43</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1093/ije/dyt228</pub-id><pub-id pub-id-type="pmid">24585853</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Kweon S, Kim Y, Jang M, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43:69&#x02013;77.<pub-id pub-id-type="pmid">24585853</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>SJ</given-names></name><name><surname>Choi</surname><given-names>KS</given-names></name><name><surname>Han</surname><given-names>JC</given-names></name><name><surname>Jee</surname><given-names>D</given-names></name><name><surname>Jeoung</surname><given-names>JW</given-names></name><name><surname>Jo</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Methodology and rationale for ophthalmic examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017&#x02013;2021)</article-title><source>Korean J Ophthalmol</source><year>2021</year><volume>35</volume><fpage>295</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.3341/kjo.2021.0016</pub-id><pub-id pub-id-type="pmid">34162194</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Song SJ, Choi KS, Han JC, Jee D, Jeoung JW, Jo YJ, et al. Methodology and rationale for ophthalmic examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017&#x02013;2021). Korean J Ophthalmol. 2021;35:295&#x02013;303.<pub-id pub-id-type="pmid">34162194</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>TR</given-names></name><name><surname>Han</surname><given-names>K-D</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>CS</given-names></name><name><surname>Bae</surname><given-names>EH</given-names></name><name><surname>Ma</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Hypertension as a risk factor for retinal vein occlusion in menopausal women</article-title><source>Medicine</source><year>2021</year><volume>100</volume><fpage>e27628</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000027628</pub-id><pub-id pub-id-type="pmid">34713852</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Oh TR, Han K-D, Choi HS, Kim CS, Bae EH, Ma SK, et al. Hypertension as a risk factor for retinal vein occlusion in menopausal women. Medicine. 2021;100:e27628.<pub-id pub-id-type="pmid">34713852</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Bressler</surname><given-names>NM</given-names></name><name><surname>Miller</surname><given-names>KM</given-names></name><name><surname>Beck</surname><given-names>RW</given-names></name><name><surname>Bressler</surname><given-names>SB</given-names></name><name><surname>Glassman</surname><given-names>AR</given-names></name><name><surname>Kitchens</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Observational study of subclinical diabetic macular edema</article-title><source>Eye</source><year>2012</year><volume>26</volume><fpage>833</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1038/eye.2012.53</pub-id><pub-id pub-id-type="pmid">22441027</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Bressler NM, Miller KM, Beck RW, Bressler SB, Glassman AR, Kitchens JW, et al. Observational study of subclinical diabetic macular edema. Eye. 2012;26:833&#x02013;40.<pub-id pub-id-type="pmid">22441027</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JY</given-names></name><name><surname>Han</surname><given-names>E</given-names></name><name><surname>Yoo</surname><given-names>TK</given-names></name></person-group><article-title>Application of ChatGPT-4 to oculomics: a cost-effective osteoporosis risk assessment to enhance management as a proof-of-principles model in 3PM</article-title><source>EPMA Journal</source><year>2024</year><volume>15</volume><fpage>659</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1007/s13167-024-00378-0</pub-id><pub-id pub-id-type="pmid">39635018</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Choi JY, Han E, Yoo TK. Application of ChatGPT-4 to oculomics: a cost-effective osteoporosis risk assessment to enhance management as a proof-of-principles model in 3PM. EPMA Journal. 2024;15:659&#x02013;76.<pub-id pub-id-type="pmid">39635018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>TK</given-names></name><name><surname>Ryu</surname><given-names>IH</given-names></name><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>IS</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Explainable machine learning approach as a tool to understand factors used to select the refractive surgery technique on the expert level</article-title><source>Transl Vis Sci Technol</source><year>2020</year><volume>9</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1167/tvst.9.2.8</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Yoo TK, Ryu IH, Choi H, Kim JK, Lee IS, Kim JS, et al. Explainable machine learning approach as a tool to understand factors used to select the refractive surgery technique on the expert level. Transl Vis Sci Technol. 2020;9:1&#x02013;8.</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Yoo</surname><given-names>TK</given-names></name><name><surname>Koh</surname><given-names>K</given-names></name></person-group><article-title>Code-free machine learning approach for EVO-ICL vault prediction: a retrospective two-center study</article-title><source>Transl Vis Sci Technol</source><year>2024</year><volume>13</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1167/tvst.13.4.4</pub-id><pub-id pub-id-type="pmid">38564200</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Shin D, Choi H, Kim D, Park J, Yoo TK, Koh K. Code-free machine learning approach for EVO-ICL vault prediction: a retrospective two-center study. Transl Vis Sci Technol. 2024;13:4.<pub-id pub-id-type="pmid">38564200</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>TK</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Choi</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>WH</given-names></name><name><surname>Oh</surname><given-names>E</given-names></name><etal/></person-group><article-title>Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learning</article-title><source>Yonsei Med J</source><year>2013</year><volume>54</volume><fpage>1321</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.3349/ymj.2013.54.6.1321</pub-id><pub-id pub-id-type="pmid">24142634</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Yoo TK, Kim SK, Kim DW, Choi JY, Lee WH, Oh E, et al. Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learning. Yonsei Med J. 2013;54:1321&#x02013;30.<pub-id pub-id-type="pmid">24142634</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>J</given-names></name><name><surname>Basavarajappa</surname><given-names>L</given-names></name><name><surname>Hoyt</surname><given-names>K</given-names></name><name><surname>Parker</surname><given-names>KJ</given-names></name></person-group><article-title>Disease-specific imaging utilizing support vector machine classification of H-scan parameters: assessment of steatosis in a rat model</article-title><source>IEEE Trans Ultrason Ferroelectr Freq Control</source><year>2022</year><volume>69</volume><fpage>720</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1109/TUFFC.2021.3137644</pub-id><pub-id pub-id-type="pmid">34936555</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Baek J, Basavarajappa L, Hoyt K, Parker KJ. Disease-specific imaging utilizing support vector machine classification of H-scan parameters: assessment of steatosis in a rat model. IEEE Trans Ultrason Ferroelectr Freq Control. 2022;69:720&#x02013;31.<pub-id pub-id-type="pmid">34936555</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Arredondo</surname><given-names>A</given-names></name></person-group><article-title>Diabetes duration, HbA1c, and cause-specific mortality in Mexico</article-title><source>Lancet Diabetes Endocrinol</source><year>2018</year><volume>6</volume><fpage>429</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(18)30098-6</pub-id><pub-id pub-id-type="pmid">29567073</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Arredondo A. Diabetes duration, HbA1c, and cause-specific mortality in Mexico. Lancet Diabetes Endocrinol. 2018;6:429&#x02013;31.<pub-id pub-id-type="pmid">29567073</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>R</given-names></name><name><surname>Wagner</surname><given-names>SK</given-names></name><name><surname>Keane</surname><given-names>PA</given-names></name></person-group><article-title>Optical coherence tomography in the 2020s&#x02014;outside the eye clinic</article-title><source>Eye</source><year>2021</year><volume>35</volume><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1038/s41433-020-01263-6</pub-id><pub-id pub-id-type="pmid">33168975</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Chopra R, Wagner SK, Keane PA. Optical coherence tomography in the 2020s&#x02014;outside the eye clinic. Eye. 2021;35:236&#x02013;43.<pub-id pub-id-type="pmid">33168975</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>AJ</given-names></name><name><surname>Ayanian</surname><given-names>S</given-names></name><name><surname>Qian</surname><given-names>R</given-names></name><name><surname>Core</surname><given-names>MA</given-names></name><name><surname>Heaton</surname><given-names>HA</given-names></name><name><surname>Lamb</surname><given-names>MW</given-names></name><etal/></person-group><article-title>A clinician&#x02019;s guide to running custom machine-learning models in an electronic health record environment</article-title><source>Mayo Clin Proc</source><year>2023</year><volume>98</volume><fpage>445</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/j.mayocp.2022.11.019</pub-id><pub-id pub-id-type="pmid">36868752</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Ryu AJ, Ayanian S, Qian R, Core MA, Heaton HA, Lamb MW, et al. A clinician&#x02019;s guide to running custom machine-learning models in an electronic health record environment. Mayo Clin Proc. 2023;98:445&#x02013;50.<pub-id pub-id-type="pmid">36868752</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Hartley</surname><given-names>K</given-names></name><name><surname>Hayak</surname><given-names>M</given-names></name><name><surname>Ko</surname><given-names>UH</given-names></name></person-group><article-title>Artificial intelligence supporting independent student learning: an evaluative case study of ChatGPT and learning to code</article-title><source>Educ Sci</source><year>2024</year><volume>14</volume><fpage>120</fpage><pub-id pub-id-type="doi">10.3390/educsci14020120</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Hartley K, Hayak M, Ko UH. Artificial intelligence supporting independent student learning: an evaluative case study of ChatGPT and learning to code. Educ Sci. 2024;14:120.</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Varma</surname><given-names>R</given-names></name><name><surname>Macias</surname><given-names>GL</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Pe&#x000f1;a</surname><given-names>FY</given-names></name><name><surname>Azen</surname><given-names>SP</given-names></name><etal/></person-group><article-title>Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study</article-title><source>Ophthalmology</source><year>2007</year><volume>114</volume><fpage>1332</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2006.10.023</pub-id><pub-id pub-id-type="pmid">17306879</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Varma R, Macias GL, Torres M, Klein R, Pe&#x000f1;a FY, Azen SP, et al. Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. Ophthalmology. 2007;114:1332&#x02013;40.<pub-id pub-id-type="pmid">17306879</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Varma</surname><given-names>R</given-names></name><name><surname>Bressler</surname><given-names>NM</given-names></name><name><surname>Doan</surname><given-names>QV</given-names></name><name><surname>Gleeson</surname><given-names>M</given-names></name><name><surname>Danese</surname><given-names>M</given-names></name><name><surname>Bower</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Prevalence of and risk factors for diabetic macular edema in the United States</article-title><source>JAMA Ophthalmol</source><year>2014</year><volume>132</volume><fpage>1334</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2014.2854</pub-id><pub-id pub-id-type="pmid">25125075</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Varma R, Bressler NM, Doan QV, Gleeson M, Danese M, Bower JK, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132:1334&#x02013;40.<pub-id pub-id-type="pmid">25125075</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Dagliati</surname><given-names>A</given-names></name><name><surname>Marini</surname><given-names>S</given-names></name><name><surname>Sacchi</surname><given-names>L</given-names></name><name><surname>Cogni</surname><given-names>G</given-names></name><name><surname>Teliti</surname><given-names>M</given-names></name><name><surname>Tibollo</surname><given-names>V</given-names></name><etal/></person-group><article-title>Machine learning methods to predict diabetes complications</article-title><source>J Diabetes Sci Technol</source><year>2018</year><volume>12</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1177/1932296817706375</pub-id><pub-id pub-id-type="pmid">28494618</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Dagliati A, Marini S, Sacchi L, Cogni G, Teliti M, Tibollo V, et al. Machine learning methods to predict diabetes complications. J Diabetes Sci Technol. 2018;12:295&#x02013;302.<pub-id pub-id-type="pmid">28494618</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MM</given-names></name><name><surname>Rahman</surname><given-names>MJ</given-names></name><name><surname>Rabby</surname><given-names>MS</given-names></name><name><surname>Alam</surname><given-names>MJ</given-names></name><name><surname>Pollob</surname><given-names>SMAI</given-names></name><name><surname>Ahmed</surname><given-names>NAMF</given-names></name><etal/></person-group><article-title>Predicting the risk of diabetic retinopathy using explainable machine learning algorithms</article-title><source>Diabetes Metab Syndr Clin Res Rev</source><year>2023</year><volume>17</volume><fpage>102919</fpage><pub-id pub-id-type="doi">10.1016/j.dsx.2023.102919</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Islam MM, Rahman MJ, Rabby MS, Alam MJ, Pollob SMAI, Ahmed NAMF, et al. Predicting the risk of diabetic retinopathy using explainable machine learning algorithms. Diabetes Metab Syndr Clin Res Rev. 2023;17:102919.</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Nusinovici</surname><given-names>S</given-names></name><name><surname>Tham</surname><given-names>YC</given-names></name><name><surname>Chak Yan</surname><given-names>MY</given-names></name><name><surname>Wei Ting</surname><given-names>DS</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Sabanayagam</surname><given-names>C</given-names></name><etal/></person-group><article-title>Logistic regression was as good as machine learning for predicting major chronic diseases</article-title><source>J Clin Epidemiol</source><year>2020</year><volume>122</volume><fpage>56</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2020.03.002</pub-id><pub-id pub-id-type="pmid">32169597</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Nusinovici S, Tham YC, Chak Yan MY, Wei Ting DS, Li J, Sabanayagam C, et al. Logistic regression was as good as machine learning for predicting major chronic diseases. J Clin Epidemiol. 2020;122:56&#x02013;69.<pub-id pub-id-type="pmid">32169597</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Christodoulou</surname><given-names>E</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>GS</given-names></name><name><surname>Steyerberg</surname><given-names>EW</given-names></name><name><surname>Verbakel</surname><given-names>JY</given-names></name><name><surname>Van Calster</surname><given-names>B</given-names></name></person-group><article-title>A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models</article-title><source>J Clin Epidemiol</source><year>2019</year><volume>110</volume><fpage>12</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2019.02.004</pub-id><pub-id pub-id-type="pmid">30763612</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12&#x02013;22.<pub-id pub-id-type="pmid">30763612</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Oosterhoff</surname><given-names>JHF</given-names></name><name><surname>Gravesteijn</surname><given-names>BY</given-names></name><name><surname>Karhade</surname><given-names>AV</given-names></name><name><surname>Jaarsma</surname><given-names>RL</given-names></name><name><surname>Kerkhoffs</surname><given-names>GMMJ</given-names></name><name><surname>Ring</surname><given-names>D</given-names></name><etal/></person-group><article-title>Feasibility of machine learning and logistic regression algorithms to predict outcome in orthopaedic trauma surgery</article-title><source>JBJS</source><year>2022</year><volume>104</volume><fpage>544</fpage><pub-id pub-id-type="doi">10.2106/JBJS.21.00341</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Oosterhoff JHF, Gravesteijn BY, Karhade AV, Jaarsma RL, Kerkhoffs GMMJ, Ring D, et al. Feasibility of machine learning and logistic regression algorithms to predict outcome in orthopaedic trauma surgery. JBJS. 2022;104:544.</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Kavakiotis</surname><given-names>I</given-names></name><name><surname>Tsave</surname><given-names>O</given-names></name><name><surname>Salifoglou</surname><given-names>A</given-names></name><name><surname>Maglaveras</surname><given-names>N</given-names></name><name><surname>Vlahavas</surname><given-names>I</given-names></name><name><surname>Chouvarda</surname><given-names>I</given-names></name></person-group><article-title>Machine learning and data mining methods in diabetes research</article-title><source>Comput Struct Biotechnol J</source><year>2017</year><volume>15</volume><fpage>104</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2016.12.005</pub-id><pub-id pub-id-type="pmid">28138367</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kavakiotis I, Tsave O, Salifoglou A, Maglaveras N, Vlahavas I, Chouvarda I. Machine learning and data mining methods in diabetes research. Comput Struct Biotechnol J. 2017;15:104&#x02013;16.<pub-id pub-id-type="pmid">28138367</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Bhagat</surname><given-names>N</given-names></name><name><surname>Grigorian</surname><given-names>RA</given-names></name><name><surname>Tutela</surname><given-names>A</given-names></name><name><surname>Zarbin</surname><given-names>MA</given-names></name></person-group><article-title>Diabetic macular edema: pathogenesis and treatment</article-title><source>Surv Ophthalmol</source><year>2009</year><volume>54</volume><fpage>1</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.survophthal.2008.10.001</pub-id><pub-id pub-id-type="pmid">19171208</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54:1&#x02013;32.<pub-id pub-id-type="pmid">19171208</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>SJ</given-names></name><name><surname>Ahn</surname><given-names>SJ</given-names></name><name><surname>Ahn</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name></person-group><article-title>Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects</article-title><source>Invest Ophthalmol Vis Sci</source><year>2011</year><volume>52</volume><fpage>7697</fpage><lpage>7703</lpage><pub-id pub-id-type="doi">10.1167/iovs.11-7784</pub-id><pub-id pub-id-type="pmid">21873679</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Woo SJ, Ahn SJ, Ahn J, Park KH, Lee K. Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects. Invest Ophthalmol Vis Sci. 2011;52:7697&#x02013;703.<pub-id pub-id-type="pmid">21873679</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Delsoz</surname><given-names>M</given-names></name><name><surname>Raja</surname><given-names>H</given-names></name><name><surname>Madadi</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>AA</given-names></name><name><surname>Wirostko</surname><given-names>BM</given-names></name><name><surname>Kahook</surname><given-names>MY</given-names></name><etal/></person-group><article-title>The use of ChatGPT to assist in diagnosing glaucoma based on clinical case reports</article-title><source>Ophthalmol Ther</source><year>2023</year><volume>12</volume><fpage>3121</fpage><lpage>3132</lpage><pub-id pub-id-type="doi">10.1007/s40123-023-00805-x</pub-id><pub-id pub-id-type="pmid">37707707</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Delsoz M, Raja H, Madadi Y, Tang AA, Wirostko BM, Kahook MY, et al. The use of ChatGPT to assist in diagnosing glaucoma based on clinical case reports. Ophthalmol Ther. 2023;12:3121&#x02013;32.<pub-id pub-id-type="pmid">37707707</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Strzalkowski</surname><given-names>P</given-names></name><name><surname>Strzalkowska</surname><given-names>A</given-names></name><name><surname>Chhablani</surname><given-names>J</given-names></name><name><surname>Pfau</surname><given-names>K</given-names></name><name><surname>Errera</surname><given-names>M-H</given-names></name><name><surname>Roth</surname><given-names>M</given-names></name><etal/></person-group><article-title>Evaluation of the accuracy and readability of ChatGPT-4 and Google Gemini in providing information on retinal detachment: a multicenter expert comparative study</article-title><source>Int J Retina Vitreous</source><year>2024</year><volume>10</volume><fpage>61</fpage><pub-id pub-id-type="doi">10.1186/s40942-024-00579-9</pub-id><pub-id pub-id-type="pmid">39223678</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Strzalkowski P, Strzalkowska A, Chhablani J, Pfau K, Errera M-H, Roth M, et al. Evaluation of the accuracy and readability of ChatGPT-4 and Google Gemini in providing information on retinal detachment: a multicenter expert comparative study. Int J Retina Vitreous. 2024;10:61.<pub-id pub-id-type="pmid">39223678</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Han</surname><given-names>Q-L</given-names></name><etal/></person-group><article-title>A brief overview of ChatGPT: the history, status quo and potential future development</article-title><source>IEEE/CAA JAS</source><year>2023</year><volume>10</volume><fpage>1122</fpage><lpage>1136</lpage></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Wu T, He S, Liu J, Sun S, Liu K, Han Q-L, et al. A brief overview of ChatGPT: the history, status quo and potential future development. IEEE/CAA JAS. 2023;10:1122&#x02013;36.</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>SM</given-names></name><name><surname>Sliwinski</surname><given-names>MJ</given-names></name><name><surname>Flaherty</surname><given-names>BP</given-names></name></person-group><article-title>Understanding ageing: further commentary on the limitations of cross-sectional designs for ageing research</article-title><source>Gerontology</source><year>2002</year><volume>48</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1159/000048920</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Hofer SM, Sliwinski MJ, Flaherty BP. Understanding ageing: further commentary on the limitations of cross-sectional designs for ageing research. Gerontology. 2002;48:22&#x02013;9.</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Sivaprasad</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>B</given-names></name><name><surname>Crosby-Nwaobi</surname><given-names>R</given-names></name><name><surname>Evans</surname><given-names>J</given-names></name></person-group><article-title>Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective</article-title><source>Surv Ophthalmol</source><year>2012</year><volume>57</volume><fpage>347</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.survophthal.2012.01.004</pub-id><pub-id pub-id-type="pmid">22542913</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol. 2012;57:347&#x02013;70.<pub-id pub-id-type="pmid">22542913</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>